Decision to list negative pressure wound therapy and Prontosan woundcare products supplied by Intermed Medical Limited

Hospital devices

Decision

We are pleased to announce the approval of a listing agreement with Intermed Medical Limited (“Intermed”) for the supply of Negative Pressure Wound Therapy Equipment and Consumables (“NPWT Products”) and Prontosan wound care products (“Prontosan Products”

What we are doing

We are pleased to announce the approval of a listing agreement with Intermed Medical Limited (“Intermed”) for the supply of Negative Pressure Wound Therapy Equipment and Consumables (“NPWT Products”) and Prontosan wound care products (“Prontosan Products”) to DHBs.

In summary, this will result in:

  • Intermed’s NPWT Products being listing on the Pharmaceutical Schedule from 1 May 2018 under a national agreement that all DHBs may purchase, rent or lease under (the “Agreement”).
  • DHBs being able to continue purchasing other supplier’s brands of NPWT Products as the Agreement is not for sole supply.
  • Prontosan Products being added to Intermed’s national Woundcare listing agreement that has been incorporated into the NPWT Agreement.

Any changes to the original proposal?

This decision was subject to a consultation letter dated 9 March 2018.  There have been no changes to the listing Agreement as a result of consultation feedback.

Who we think will be most interested

  • Suppliers and wholesalers
  • DHB staff
    • Wound Care Clinicians
    • Community Nursing Services
    • Clinical Engineers
    • Procurement Officers

Detail about this decision

NPWT

In June 2017 PHARMAC issued a request for proposals (“RFP”) for NPWT Products.  The RFP requested proposals for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

After completing the RFP evaluation process, and consulting on the provisional Agreement reached with Intermed, PHARMAC has decided to list Intermed’s range of NPWT Products in Part III of Section H of the Pharmaceutical Schedule from 1 May 2018.

Intermed’s range of NPWT Products includes reusable NPWT units, disposable NPWT units, and associated consumables.

Procurement options and brands for the reusable NPWT units included in the Agreement are:

Procurement options Reusable NPWT units
Outright Purchase VAC Therapy – ActiVAC
VAC Veraflo Therapy – VAC Ulta
Casual Daily Rental VAC Therapy – ActiVAC
VAC Veraflo Therapy – VAC Ulta
VAC Therapy – InfoVAC
Flexi-Rent Supplier Managed VAC Therapy – ActiVAC
VAC Veraflo Therapy – VAC Ulta
VAC Therapy – InfoVAC
Flexi-Rent DHB Managed VAC Therapy – ActiVAC
VAC Veraflo Therapy – VAC Ulta
VAC Therapy – InfoVAC
Fixed Fleet Rental VAC Therapy – ActiVAC
VAC Veraflo Therapy – VAC Ulta
VAC Therapy – InfoVAC
Long Term Lease VAC Therapy – ActiVAC
VAC Veraflo Therapy – VAC Ulta

Brands of NPWT consumables (including disposable NPWT units) included in the Agreement are:

  • VAC Therapy
  • VAC Ulta
  • VAC Via
  • ABTHERA
  • Prevena
  • Prevena Plus
  • Prontosan (with Veraflo adaptor)
  • Nanova

DHBs can continue to choose which NPWT Products they procure.

The Agreement includes terms for training and education services to be provided by Intermed to DHB personnel on appropriate use of its NPWT Products, which is to be provided at times as agreed with individual DHBs.

The Agreement sets out respective responsibilities for maintenance and management of equipment under the various procurement options.

PHARMAC has been working with a range of suppliers to seek agreements and this Agreement is the latest to arise from that process.  Further consultations in this category are expected over the next few months.

Prontosan

Intermed’s Prontosan Products include a range of antimicrobial wound care solutions and hydrogels. Prontosan Products were included in Intermed’s original Woundcare proposal however were not included the resulting agreement as PHARMAC needed to confirm which part of the Pharmaceutical Schedule this type of product would be included in.

PHARMAC has confirmed that, based on the Pharmaceutical Schedule Rules, it would be appropriate to treat Intermed’s proposed Prontosan Products as Woundcare medical devices. Following consultation on a provisional agreement with Intermed, PHARMAC has decided to list Prontosan Products in Part III of Section H of the Pharmaceutical Schedule.

Listing

The list of products will be available on PHARMAC's website from 1 May 2018, in both a PDF document and an Excel spreadsheet.

DHBs that procure Intermed’s NPWT Products and Prontosan Products must do so under the terms and conditions, and at the prices, included in the Agreement, from 1 May 2018.

Our response to what you told us

We appreciate the time people time people took to respond to this consultation.

All consultation responses received by 4 April 2018 were considered in their entirety in making a decision to approve Intermed’s provisional Agreement.

A summary of the main themes raised in feedback and our responses to the feedback are set out below: 

Theme

Comment

Requests for information regarding application processes for various wound care products.

PHARMAC has provided information directly to each respondent, relevant to their specific enquiry.

Feedback that no technical or resource impacts are expected as a result of the proposal.

Noted.

 If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.